Skip to main content
. Author manuscript; available in PMC: 2007 Feb 19.
Published in final edited form as: J Burn Care Rehabil. 2004;25(4):337–345. doi: 10.1097/01.BCR.0000132168.02947.A1

Figure 4.

Figure 4

Enhanced vascularization of vascular endothelial growth factor-modified cultured skin substitutes (CSS) prepared without human endothelial cells. Mouse endothelial cells in sections of CSS from 1 week (A, B) or 3 weeks (C, D) after grafting to mice were stained with an antibody specific for mouse CD31. A and C. Control CSS (group 3). B and D. Vascular endothelial growth factor-modified CSS (group 4). Dotted white lines indicate the locations of the dermal–epidermal junctions; sections are oriented with the epidermis at the top of each panel.